Towards identification of immune and genetic correlates of severe influenza disease in Indigenous Australians.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed, 44 citations in OpenAlex.

1. Molecular basis for universal HLA-A*0201-restricted CD8+ T-cell immunity against influenza viruses.Proceedings of the National Academy of Sciences of the United States of America · 2016
   Trial
2. An archaic HLA class I receptor allele diversifies natural killer cell-driven immunity in First Nations peoples of Oceania.Cell · 2024
   Article
3. The ABC of Major Histocompatibility Complexes and T Cell Receptors in Health and Disease.Viral immunology · 2020
   Review
4. Health Challenges of the Pacific Region: Insights From History, Geography, Social Determinants, Genetics, and the Microbiome.Frontiers in immunology · 2019
   Review

Corrections and comments

• Erratum for
  Towards identification of immune and genetic correlates of severe influenza disease in Indigenous Australians.2016

Authors and funding

9 authors at 5 institutions in 2 countries.

Funding

No grant is acknowledged in the PubMed record.

Abstract